Weight Management
Tirzepatide 5mg
Dual GIP/GLP-1 receptor agonist with synergistic incretin activity. Demonstrates superior glycemic control and weight reduction compared to selective GLP-1 agonists. Next-generation metabolic research compound.
Research specifications
- Purity
- ≥98%
- Unit
- 5mg
- Sequence
- YXEGTFTSDYSIXLDKIAQKAFVQWLIAGGPSSGAPPPS
- Length
- 39 amino acids
- Molecular weight
- 4813.5
- Availability
- In stock